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Abstract
Human papillomaviruses (HPV) exhibit constitutive activation of ATM and ATR DNA damage 
response (DDR) pathways, which are required for productive viral replication. Expression of 
HPV31 E7 alone is sufficient to activate the DDR through an unknown mechanism. Here, we 
demonstrate that the E7 Rb binding domain is required to increase levels of many DDR proteins, 
including ATM, Chk2, Chk1, the MRN components MRE11, Rad50, and NBS1, as well as the 
homologous recombination repair proteins BRCA1 and Rad51. Interestingly, we have found that 
the increase in these DNA repair proteins does not occur solely at the level of transcription, but 
that E7 broadly increases the half-life of these DDR factors, a phenotype that is lost in the E7 Rb 
binding mutant. These data suggest that HPV-31 upregulates DNA repair factors necessary for 
replication by increasing protein half-life in a manner requiring the E7 Rb binding domain.
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1. Introduction
High-risk human papillomaviruses (HPV) are the etiological agents of cervical cancer, and 
are also associated with other genital malignancies, as well as an increasing number of head 
and neck cancers (zur Hausen, 2009). HPV has adapted its life cycle to be linked closely 
with epithelial differentiation, with late viral events being restricted to the uppermost layers 
of the epithelium (Longworth and Laimins, 2004b). HPV is thought to infect dividing, basal 
cells of the stratified epithelium through a microwound, where upon entry into the nucleus, 
the virus is maintained as a low copy episome. As an infected cell divides, one daughter cell 
migrates upward and initiates differentiation. Differentiation triggers the productive phase of 
the viral life cycle, which requires cellular factors. HPV maintains differentiating cells active 
in the cell cycle through viral gene expression, allowing for initiation of DNA synthesis and 
amplification of viral genomes to thousands of copies per cell. Late gene expression, as well 
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as virion assembly and release occur concomitantly with productive replication (Moody and 
Laimins, 2010).
Previous studies demonstrated that the productive replication of high-risk HPV31 requires 
activation of an ATM-dependent DNA damage response (DDR) (Moody and Laimins, 
2009). ATM is a serine/threonine kinase that is activated primarily in response to double 
strand DNA breaks (DSBs), resulting in phosphorylation of a variety of substrates important 
in activating cell cycle checkpoints, as well as DNA repair (Ciccia and Elledge, 2010). If left 
unrepaired, DSBs have the potential to generate chromosomal translocations, aneuploidy, 
and increased incidence of malignancy (Agarwal et al., 2006; Helleday et al., 2007). Though 
the DNA damage response plays a crucial role in the maintenance of genomic stability, 
many viruses have been shown to exploit repair pathways to facilitate replication 
(Hollingworth and Grand, 2015; Ryan et al., 2016). We have previously shown that DNA 
repair factors localize to sites of HPV replication, indicating a direct role for these factors in 
efficient viral replication (Gillespie et al., 2012). In support of this, we have found that the 
histone variant H2AX, one of the first targets of ATM, is bound to HPV DNA (Gillespie et 
al., 2012). In addition, we recently demonstrated that the MRN complex (Mre11, Rad50, 
Nbs1), which facilitates ATM activation in response to ionizing radiation (Lee and Paull, 
2004, 2005; Paull and Lee, 2005), is localized to HPV31 genomes and required for 
productive replication (Anacker et al., 2014). In addition, we have found that Rad51 and 
BRCA1, two factors essential for repair of DSBs through homologous recombination 
(Ciccia and Elledge, 2010), are required for productive viral replication (Chappell et al., 
2015). Although numerous studies support a role for the ATM pathway in productive 
replication of HPV (Anacker et al., 2014; Chappell et al., 2015; Gillespie et al., 2012; Hong 
et al., 2015b; Hong and Laimins, 2013; Moody and Laimins, 2009), the mechanism by 
which ATM is activated in HPV-infected cells remains unclear.
The E6 and E7 oncoproteins of high-risk HPV types contribute to carcinogenesis largely 
through their ability to target the tumor suppressors p53 and Rb for degradation, respectively 
(Howie et al., 2009; Roman and Munger, 2013). This is especially important upon 
differentiation, as E6 and E7 ensure virus production by promoting S-phase re-entry of a 
subset of differentiating cells (Moody and Laimins, 2010). The ability of E6 and E7 to target 
critical regulators of cell cycle progression results in the bypass of checkpoints normally 
involved in the elimination of abnormal cells (Munger et al., 2004). While this is necessary 
for viral replication, checkpoint abrogation can also result in genomic instability in HPV-
immortalized cells that eventually leads to cancer (Solinas-Toldo et al., 1997). High-risk E7 
expression has been shown to lead to DSB induction and genomic instability in a manner 
thought to be dependent on Rb inactivation and deregulation of E2F transcription factors 
(Bester et al., 2011; Duensing and Munger, 2002; Pickering and Kowalik, 2006). 
Inactivation of Rb outside the context of HPV infection is sufficient to induce DSBs, 
formation of γH2AX and MRE11 positive foci, and increase levels of ATM, Chk2, and 
Chk1 (Frame et al., 2006; Pickering and Kowalik, 2006; Shamma et al., 2013, 2009). 
Previous studies demonstrated that expression of high-risk HPV31 E7 alone is sufficient to 
induce ATM signaling (Moody and Laimins, 2009), raising the possibility that E7 
contributes to the differentiation-dependent phase of the life cycle through modulation of the 
DDR. More recent studies by Hong et al. demonstrated that the phosphorylation of STAT5 is 
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required for ATM activation in HPV31 positive cells, potentially through E7-mediated Rb 
inactivation (Hong et al., 2015b; Hong and Laimins, 2013). Studies by this same group have 
also provided a link between STAT5, activation of the ATR DNA damage kinase and 
productive replication of HPV31 (Hong et al., 2015a). Although Rb inactivation by E7 is 
important for providing an environment conducive to productive viral replication, whether a 
direct link exists between Rb binding and ATM/ATR activation has not been demonstrated. 
However, recent studies linked the development of female reproductive tract cancers, as well 
as head and neck cancers in HPV16 transgenic mice to E7-mediated inactivation of pocket 
proteins (Rb, p107, p130) and resultant DNA damage (Park et al., 2014, 2013).
In this study, we investigated whether the Rb binding domain of E7 is required for activation 
of ATM, as well as ATR signaling pathways in HPV31 positive cells. We have found that 
deletion of the Rb binding domain in the context of the HPV31 genome results in decreased 
levels of DNA repair factors compared to cells maintaining wild-type HPV31 genomes. A 
similar phenotype was observed in cells expressing wild-type HPV31 E7 alone compared to 
cells expressing an E7 Rb binding mutant. Interestingly, we found that E7 maintains high 
levels of DNA repair factors required for productive replication through increased protein 
stability, rather than exclusively through increased gene expression, with exceptions limited 
to the ATR target Chk1, and the homologous recombination repair factors BRCA1 and 
Rad51. Together, these data suggests that the E7 Rb binding domain is important for 
increased ATM/ATR activation by virtue of increasing total protein levels through increased 
protein stability, and that increases in DNA repair factor levels in HPV positive cells 
depends largely on the ability of E7 to bind and target Rb for degradation.
2. Materials and methods
2.1. Cell culture
Human foreskin keratinocytes (HFKs) were isolated from neonatal foreskins as previously 
described and were cultured in E medium supplemented with 5 ng/ml mouse epidermal 
growth factor (EGF; BD Biosciences) (Wilson and Laimins, 2005). HFK-31, HFK-31 
ΔLHCYE, pLXSN-31 E7, pLXSN-31 E7 ΔLHCYE cells were also cultured in E medium 
supplemented with 5 ng/ml mouse epidermal growth factor. All lines were cultured in the 
presence of mitomycin C-treated J2 3T3 fibroblast feeder cells, as previously described 
(Wilson and Laimins, 2005). J2 feeder cells were removed from HPV-positive cells with 1 
mM EDTA in phospho-buffered saline (PBS) as necessary.
2.2. Plasmids
The pBR322-HPV31 plasmids containing the wild-type HPV31, HPV31 E7 ΔLHCYE 
mutant genomes have been previously described (Hubert and Laimins, 2002; Longworth and 
Laimins, 2004a). Briefly, the E7 ΔLHCYE plasmid contains an in-frame deletion of the Rb 
binding site. The pLXSN retroviral vectors encoding wild-type HPV31 E7 and the E7-Rb 
binding mutant (ΔLHCYE) have been described previously (Longworth and Laimins, 
2004a).
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2.3. Generation of HFK-31 lines
HFKs maintaining wild type HPV31, as well as mutant HPV 31 genomes (HFK-31 E7 
ΔLHCYE) were generated as previously described (Wilson and Laimins, 2005). Briefly, 
HPV genomes were digested with HindIII to release them from the pBR322 plasmid 
backbone. T4 DNA ligase (Life Technologies) was then used to religate the excised HPV 
genomes. HFKs were co-transfected with 2.5 μg of ligated HPV genomes and 2.5 μg of 
pSV2-neo using PolyJet transfection reagent as per the manufacturer’s instructions 
(Signagen Laboratories), followed by selection in G418 (Sigma). Surviving populations 
were expanded for further analysis.
2.4. Keratinocyte differentiation
Differentiation of keratinocytes was performed by suspending cells in 1.5% methylcellulose, 
as previously described (Wilson and Laimins, 2005). Cells were harvested as an 
undifferentiated sample (T0), as well as 24 and 48hrs after suspension in methylcellulose. At 
each time point, DNA, RNA and protein were harvested.
2.5. Western blot analysis
Whole cell lysates were harvested by lysing cell pellets in RIPA buffer supplemented with 
Complete Mini protease inhibitor (Thermo Scientific) and PhoSTOP phosphatase inhibitor 
tablets (Roche). Total protein concentrations were determined by Bio-Rad protein assay 
(Bio-Rad). Equal amounts of protein were separated by SDS-page and transferred to 
polyvinylidene difluoride (PVDF) membranes. (Immobilon-P; Millipore). The following 
primary antibodies were used: phospho-ATM Ser1981, Chk1, NBS1 (Abcam); ATM (Bethyl 
laboratories); phospho-Chk1 Ser345, phospho-Chk2 Ser68, Chk2, E2F1 (Cell Signaling 
Technology); E2F2, E2F3, GAPDH, Rad51 (Santa Cruz); MRE11, Rad50, and BRCA1 
(GeneTex). Secondary antibodies used were horseradish peroxidase (HRP)-conjugated anti-
rabbit (Cell Signaling Technology) and HRP-conjugated anti-mouse (GE Life Sciences). 
Western blots were developed using Enhanced Chemiluminescence Prime blotting substrate 
(GE Life Sciences). Images were captured with the Biorad ChemidocMP imaging system, 
and analyzed with Biorad Imagelab 5.0 software.
2.6. Southern Blot Analysis
DNA isolation and Southern blotting were performed as previously described (Fehrmann et 
al., 2003). Briefly, cells were harvested in DNA lysis buffer (400 mM NaCl, 10 mM Tis pH 
7.5 and 10 mM EDTA), then lysed by the addition of 30uL 20% SDS. Samples were 
subsequently treated with 15 ul of 10 mg/ml proteinase K overnight at 37 °C. DNA was 
extracted using phenol chloroform, followed by ethanol precipitation in the presence of 
sodium acetate. 5 μg of DNA was digested with either BamHI (New England Biolabs) (does 
not cut the genome), or HindIII (New England Biolabs) (cuts the genome once). DNAs were 
resolved on a 0.8% agarose gel for 15 h at 40 V and were then transferred to a positively 
charged nylon membrane (Immobilon-Ny+; EMD Millipore). The DNA was fixed to the 
membrane via UV irradiation and then hybridized to a radioactive DNA probe consisting 
of 32P-labeled linearized HPV31 genome.
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2.7. Real-time PCR
RNA was extracted from primary HFKs, HFK-31, HFK-31 ΔLHCYE, pLXSN, pLXSN-31 
E7, and pLXSN-31 E7 ΔLHCYE cells using RNA STAT 60 (Tel-test). DNA was removed 
from samples via treatment with RQ1 DNAse (Promega) via the manufacturer’s protocol. 
cDNA was made using the iScript reverse transcription kit (Bio-Rad). Quantitative RT-PCR 
was performed in triplicate on 50 ng of cDNA using 375 nM primers and iTaq Universal 
SYBR Green Supermix (Bio-Rad) in a total reaction volume of 10 μl. Reactions were 
performed using an ABI QuantStudio 6 Flex thermal cycler and analyzed with version 1.0 of 
the QuantStudio 6 and 7 Flex software. The thermal profile used for PCR is as follows: 10 
min denaturation at 95 °C followed by 40 cycles of 95 °C for 15 s, then 60 s at 60 °C (ATM, 
Chk2, Chk1, MRE11, Rad50, NBS1, E2F2, E7) or 63 °C (BRCA1, Rad51, E2F1), followed 
by 72 °C for 30 s. A melt curve was run to ensure primer annealing. Relative transcript 
levels were determined using the threshold cycle method (ΔΔCT) with GAPDH serving as 
an endogenous control gene. Values were normalized relative to transcript levels of primary 
HFKs or pLXSN control cells. The primer sequences are as follows: ATM Forward, 5′-
TGTTCCAGGACACGAAGGGAGA-3′; ATM Reverse, 5′-
CAGGGTTCTCAGCACTATGGGA-3′; BRCA1 Forward, 5′-
CTGAAGACTGCTCAGGGCTATC-3′; BRCA1 Reverse, 5′-
AGGGTAGCTGTTAGAAGGCTGG-3′; Chk1 Forward 5′-
TGAGAATCCATCAGCAAGAATTACC-3′; Chk1 Reverse, 5′-
ATCCACTGGGAGACTCTGACACA-3′; Chk2 Forward, 5′-
GCAGCAGTGCCTGTTCACA-3′; Chk2 Reverse, 5′-TGGATATGCCCTGGGACTGT-3′; 
E2F1 Reverse 5′-ATCTGTGGTGAGGGATGAGG-3′ E2F2 Forward, 5′-
CTCTCTGAGCTTCAAGCACCTG-3′; E2F2 Reverse, 5′-
CTTGACGGCAATCACTGTCTGC-3′; HPV31 E7 Forward, 5′-
ACACCTACGTTGCAAGACTATG-3′; GAPDH Forward, 5′-
CTGTTGCTGTAGCCAAATTCGT-3′; GAPDH Reverse, 5′-
ACCCACTCCTCCACCTTTGAC-3′; HPV31 E7 Reverse, 5′-
CGAATATCTACTTGTGTGCTCTGT-3′, Mre11 Forward, 5′-
GCCTTCCCGAAATGTCACTA-3′; Mre11 Reverse, 5′-
TTCAAAATCAACCCCTTTCG-3′; NBS1 Forward, 5′-
TCTGTCAGGACGGCAGGAAAGA-3′; NBS1 Reverse, 5′-
CACCCCAAAGACAACTGCGGA-3′; Rad50 Forward, 5′-
GGAAGAGCAGTTGTCCAGTTACG-3′; Rad50 Reverse, 5′-
GAGTAAACTGCTGTGGCTCCAG-3′; Rad51 Forward, 5′-
TCTCTGGCAGTGATGTCCTGGA-3′, Rad51 Reverse, 5′-
TAAAGGGCGGTGGCACTGTCTA-3′.
2.8. Measurement of protein half-life
Primary HFKs, HFK-31, HFK-31 ΔLHCYE, pLXSN, pLXSN-31E7 and pLXSN-31E7 
ΔLHCYE cells were grown in 10 cm dishes until ~80% confluency. Whole cell lysates were 
then harvested from one dish for the 0 h time point and at the indicated time points after 
treatment with 50 μg/ml cycloheximide. J2 fibroblasts were removed prior to harvest using 
Versene (1 mM EDTA in PBS). Western blot analysis was performed using 50 μg of total 
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protein as described above. Westerns were digitally imaged using the Bio-Rad Chemidoc 
MP system, and densitometry was performed with the Biorad ImageLab 5.0 software.
3. Results
3.1. The Rb binding domain of E7 is required for ATM and ATR activation in HPV31 positive 
cells
To examine the importance of the E7 Rb binding domain to DDR activation and 
maintenance of high levels of DDR factors in HPV31 positive cells, we generated human 
foreskin keratinocyte (HFKs) lines that maintain either wild-type HPV31 genomes 
(HFK-31), or genomes containing a mutation in the E7 LXCXE Rb binding domain 
(HFK-31 ΔLHCYE). Previous studies demonstrated that this mutation does not alter the 
stability of E7, and that HFK-31 ΔLHCYE mutant genomes are maintained 
extrachromosomally, though copy number decreases over time compared to wild-type 
genomes (Longworth and Laimins, 2004a). In addition, these studies showed that the E7 Rb 
binding site is required for efficient amplification of viral genomes upon differentiation 
(Longworth and Laimins, 2004a), and we have found similar results in this study (Fig. 1A). 
To determine the effect of the ΔLHCYE mutation on DDR activation throughout the viral 
life cycle, cells were harvested both prior to and after the induction of epithelial 
differentiation in methylcellulose, a method commonly used to activate the productive phase 
of the viral life cycle. We first examined the importance of the E7 Rb binding domain on the 
activation of the ATM and ATR pathways. As shown in Fig. 1B, both the phosphorylated 
and total levels of ATM, the ATM target Chk2, and the ATR target Chk1 were increased in 
HFK-31 cells compared to uninfected HFKs, indicating activation of ATM/ATR signaling 
pathways, as published previously (Hong et al., 2015a; Moody and Laimins, 2009). While 
the levels of total ATM and Chk2 decreased in HFK-31 positive cells upon differentiation, 
the phosphorylated levels of ATM and Chk2 remained elevated, suggesting that DDR 
activation is increased during the productive phase of the viral life cycle. In contrast, both 
phosphorylated and total levels of Chk1 decreased upon differentiation, despite being 
required for productive replication (Hong et al., 2015a). Interestingly, we found that the 
levels of phosphorylated and total ATM and Chk2, as well as Chk1 dramatically decreased 
in the HFK-31 ΔLHCYE cells at all time points, exhibiting levels similar to that found in the 
uninfected HFKs (Fig. 1B). These data suggest that in the setting of an HPV infection, the 
Rb binding domain of E7 is necessary for ATM and ATR activation.
Previous studies demonstrated that HPV31 E7 expression is alone sufficient to activate the 
ATM and ATR pathways in keratinocytes (Hong et al., 2015a; Moody and Laimins, 2009). 
Additionally, studies by other groups have shown that E7 expression alone induces DNA 
damage and activates the DDR (Duensing and Munger, 2002; Pickering and Kowalik, 2006). 
To determine if the E7 Rb binding domain is required for DDR activation outside the context 
of viral infection, we stably transduced HFKs with either a retroviral control vector 
(pLXSN), a vector encoding wild type HPV31 E7, or HPV31 E7 containing the ΔLHCYE 
mutation. We then analyzed ATM and ATR activation from both undifferentiated and 
methylcellulose-differentiated cells by Western blot analysis. As shown in Fig. 1C, HFKs 
expressing wild-type HPV31 E7 exhibited increased levels of both phosphorylated and total 
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ATM, Chk2, and Chk1 relative to control cells, confirming that E7 expression alone is 
sufficient to activate ATM and ATR signaling pathways. However, this phenotype was lost in 
cells expressing the E7 ΔLHCYE mutant (Fig. 1C). Overall, these results indicate that 
maintenance of high levels of ATM, Chk2 and Chk1 in HPV31 positive cells requires the Rb 
binding domain of E7, which likely contributes to the ability of HPV to activate ATM and 
ATR signaling pathways.
3.2. Maintenance of high levels of DNA repair factors in HPV31 positive cells requires the 
Rb binding domain of E7
The MRN protein complex (consisting of MRE11, Rad50, and NBS1) is a DNA damage 
sensor that activates the DDR by recognizing DSBs and activating ATM (Lee and Paull, 
2004, 2005; Paull and Lee, 2005). Previously, we showed that the levels of MRN 
components are increased in HPV31 positive cells, and that the maintenance of the MRN 
complex is necessary for productive viral replication (Anacker et al., 2014). We next wanted 
to determine if the E7 Rb binding domain is also required for the maintenance of high levels 
of MRN complex members in HPV31 positive cells. As shown in Fig. 2A, levels of all three 
MRN components were elevated in undifferentiated HFK-31 cells compared to primary 
HFKs, and this phenotype was maintained upon differentiation in methylcellulose. However, 
this phenotype was lost in cells containing E7 ΔLHCYE mutant genomes, with levels of 
MRN components resembling those found in HFKs (Fig. 2A). Similar results were observed 
in E7-expressing lines, with cells expressing the E7 ΔLHCYE mutant exhibiting levels of 
MRN components similar to that of HFKs (Fig. 2B). Together, these data suggest that the Rb 
binding site of E7 is necessary for maintenance of high levels of MRN components in 
HPV31 positive cells.
BRCA1 and Rad51 are two proteins essential to homologous recombination, a DSB repair 
mechanism that also requires ATM activity (Ciccia and Elledge, 2010). Previously, we 
demonstrated that levels of BRCA1 and Rad51 are increased in HPV31 positive cells and are 
required for productive viral replication (Chappell et al., 2015). As shown in Fig. 2C, 
HFK-31 cells exhibited increased levels of BRCA1 and Rad51 compared to HFKs, as 
previously reported (Chappell et al., 2015; Gillespie et al., 2012). However, the E7 ΔLHCYE 
mutation resulted in decreased BRCA1 and Rad51 levels, similar to those found in HFKs, 
indicating the E7 Rb binding domain is required for increased levels of BRCA1 and Rad51 
in HPV31 positive cells. These findings were recapitulated in cells expressing E7 alone, with 
the E7 Rb binding domain being required for maintenance of high levels of BRCA1 and 
Rad51 (Fig. 2D). Overall, these results indicate that E7 expression is necessary for HPV31 
to increase the levels of DDR factors and that this increase requires the E7 Rb binding 
domain.
3.3. Elevated levels of DNA repair factors in HPV31 positive cells cannot solely be 
explained by increased transcription
The inactivation of Rb results in the constitutive activation of a subset of E2F transcription 
factors termed the activator E2Fs (E2F1-3) that drive transcription of a number of cellular 
genes not only involved in facilitating S-phase entry, but DNA repair as well, including 
ATM, Chk1, BRCA1, and Rad51 (Bracken et al., 2004). Previous studies by the Laimins lab 
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showed that E2F2 protein levels are increased in HPV31 positive cells upon differentiation 
in a manner dependent on the E7 Rb binding domain (Longworth et al., 2005). E7 may 
therefore contribute to activation of the DDR, at least in part, by increasing transcription of 
key DNA repair genes in an E2F-dependent manner. To investigate this possibility, we first 
examined if the protein levels of the other activator E2Fs, E2F1 and E2F3, are also affected 
by the E7 ΔLHCYE mutation in HPV31 positive cells. As shown in Fig. 3A, the levels of 
E2F1 and E2F2, but not E2F3, were increased in HFK-31 cells compared to uninfected 
HFKs, and this phenotype was lost in cells containing E7 ΔLHCYE mutant genomes. We 
next confirmed these results in cells stably expressing E7 alone. As shown in Fig. 3B, while 
HFKs expressing wild-type E7 exhibited elevated E2F1 and E2F2 protein levels, this 
increase was not observed in the E7 ΔLHCYE mutant, similar to results found with the 
HFK-31 ΔLHCYE mutant genome lines (Fig. 3A). Additionally, E2F3 was regulated in a 
manner similar to E2F1 and E2F2 in E7-expressing cells (Fig. 3B), which was not observed 
within the context of the HPV genome (Fig. 3A). Given the relationship between the E7 Rb 
binding domain and maintenance of E2F proteins, we examined the possibility that E7 
increases the levels of DNA repair factors at the level of gene expression.
We first examined the effect of mutating the E7 Rb binding domain on the transcript levels 
of ATM, Chk2, and Chk1 in HPV31 genome-containing HFKs (Fig. 4). As shown in Fig. 
4A, HFK-31 cells exhibited no significant changes in transcript levels for ATM, Chk2, or 
Chk1 in comparison to uninfected HFKs, despite exhibiting substantially increased protein 
levels (Fig. 1A). While loss of the E7 Rb binding domain did slightly affect the levels of 
ATM, Chk2, and Chk1 transcripts, these changes were statistically insignificant (p > 0.05) 
(Fig. 4A). In E7-expressing HFKs, no significant changes were observed for ATM or Chk2 
transcripts compared to control cells, however, mRNA levels of ATM and Chk2 were 
reduced in the E7 ΔLHCYE mutant (Fig. 4B). For Chk1, E7-expressing cells exhibited a 
minor, though significant increase in transcript levels compared to HFKs. Similar to ATM 
and Chk2, Chk1 transcript levels were decreased in the E7 ΔLHCYE mutant cells (Fig. 4B). 
These results indicate that while elevated transcription may contribute to the increased 
protein levels of Chk1, the moderate changes in ATM and Chk2 transcript levels in HFK-31 
cells compared to HFKs cannot solely account for the high protein levels observed in 
HPV31 positive cells. In addition, the decrease in transcript levels observed in the ΔLHCYE 
mutant cannot fully account for the differences in protein levels observed in these cells and 
suggest that E7 may also regulate levels of these DDR factors in a post-transcriptional 
manner.
We next determined if loss of the Rb binding domain affects the mRNA levels of MRN 
complex components in HPV31 positive cells (Fig. 4C), as well as E7-expressing cells (Fig. 
4D) Previously, we reported that in HPV31 E7-expressing cells, MRE11 gene expression 
was slightly, though significantly elevated compared to control cells, with no change in 
Rad50 and NBS1 transcripts (Anacker et al., 2014). To confirm these results in HPV31 
positive cells and determine if loss of the Rb binding domain affects expression of MRE11, 
Rad50, and NBS1, we first examined mRNA levels in HFKs and HFK-31 cells, as well as in 
HFK-31 ΔLHCYE cells. As shown in Fig. 4C, we found no significant changes in transcript 
levels for MRE11, Rad50, or NBS1 between HFK and HFK-31 cells. Similarly, while small 
reductions in mRNA levels for MRE11, Rad50, and NBS1 were observed in HFK-31 
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ΔLHCYE cells when compared to HFK-31 cells, these changes were not significant. In 
HFKs expressing HPV31 E7 alone, we observed no significant changes between wild-type 
E7-expressing cells and the vector control for any of the MRN components (Fig. 4D). The 
disparity in these data for Mre11 and our previously published results likely owes to the very 
small changes observed in both cases (< 2 fold increase in MRE11). Similar to ATM, Chk2, 
and Chk1, we did observe a small but significant decrease in transcript levels for both 
MRE11 and NBS1, but not Rad50, in cells expressing the E7 ΔLHCYE mutant. Taken 
together, these data suggest that transcription may play a minor role in the increase in the 
MRN components observed in HPV31 positive cells, however, increased gene expression 
alone cannot fully explain the changes observed in MRN protein levels.
Previously, we demonstrated that HPV31 positive cells exhibit increased transcript levels of 
BRCA1 and Rad51, with E7 expression alone being sufficient for this increase (Chappell et 
al., 2015). To determine if the increase in gene expression requires the E7 Rb binding 
domain, we examined BRCA1 and Rad51 mRNA levels in uninfected HFKs, as well as 
HFKs containing wild-type HPV31 genomes, or E7 ΔLHCYE mutant genomes (Fig. 4E). As 
shown in Fig. 4E, transcript levels for BRCA1 and Rad51 were increased in HFK-31 cells 
compared to uninfected HFKs, and this increase was lost in cells expressing the E7 
ΔLHYCE mutant. Similar results were observed for E7-expressing cells (Fig. 4F), with 
BRCA1 and Rad51 transcripts being present at a significantly increased level compared to 
control cells, as published previously (Chappell et al., 2015). This phenotype was again lost 
in the E7 ΔLHCYE mutant (Fig. 4F), indicating that in addition to maintenance of BRCA1 
and Rad51 protein levels (Fig. 2C–D), the E7 Rb binding domain is also required for 
increased gene expression of BRCA1 and Rad51. Overall, these data suggest that E7 
regulates the levels of a subset of DDR proteins in a transcription-independent manner 
(ATM, Chk2, MRN), while conferring a mechanism of transcriptional dependence, to a 
certain extent, on other DDR factors (Chk1, BRCA1, Rad51).
3.4. The E7 Rb binding domain is required for increased protein stability of a subset of 
DNA repair factors in HPV31 positive cells
Previous studies have demonstrated that the E7 Rb binding domain is required for 
maintenance of high levels of E2F2 in a post-transcriptional manner (Longworth et al., 
2005). In addition, our lab has previously shown that BRCA1 and Rad51 exhibit an 
increased protein half-life in HPV31 positive CIN612 cells (Chappell et al., 2015). These 
studies, taken together with the observation that the transcript levels of ATM, Chk2, Chk1, 
and the MRN components were not substantially altered in HFK-31 ΔLHCYE cells raises 
the possibility that E7 may contribute to increased DDR protein levels in infected cells 
through influencing protein stability.
To determine the impact of protein stability on the maintenance of DDR factors in HPV31 
positive cells, we first examined the half-life of ATM, Chk2, and Chk1 in HKFs compared to 
HFK-31 cells using cycloheximide to inhibit protein synthesis. As shown in Fig. 5A and B 
and summarized in Table 1, the protein half-lives for ATM, Chk2, and Chk1 in HFKs were 
5.8+/−1.3, 7.0+/−0.02, and 4.5+/−0.3 h, respectively. In contrast, in HFK-31 cells the half-
lives of ATM, and Chk2 increased to greater than 12 h (the longest time point measured). 
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For Chk1, the half-life was also increased in HFK-31 cells (5.8+/−0.5 h vs. 4.5+/−0.3 in 
HFKs), though not to the same extent as ATM and Chk2. To determine if the E7 Rb binding 
domain was required for the increase in protein stability observed, we examined the half-
lives of ATM, Chk2, and Chk1 in cells containing HPV31 genomes with the ΔLHCYE 
mutation. Interestingly, in HFK-31 ΔLHCYE cells, the half-lives of ATM, Chk2, and Chk1 
were reduced to 4.5+/−0.8, 9.6+/−2.0, and 4.2+/−0.4 h, respectively, similar to the half-lives 
observed in HFKs for each protein (Fig. 5A–B, Table 1). These results suggest that high 
levels of ATM, Chk2, and Chk1 are maintained in HPV31 positive cells, at least in part, 
through an increase in protein stability.
To determine if E7 expression alone is sufficient for the increase in protein stability 
observed, we examined the half-life of ATM, Chk2, and Chk1 in HFKs expressing wild-type 
E7, as well as the E7 ΔLHCYE mutant (Fig. 5C–D). As shown in Fig. 5C and D and 
summarized in Table 2, similar to HPV31 genome-containing lines, the half-life of ATM 
increased from 4.5+/−0.3 h in HFKs to > 12 h in E7-expressing cells. In contrast, the half-
life of ATM decreased to 4.9+/−0.9 h in the E7 ΔLHCYE mutant. Similar results were 
observed for Chk2, with the half-life increasing to > 12 h in HFK-31 cells from 7.5+/−0.5 h 
in HFKs. Similar to ATM, Chk2 exhibited a reduced half-life in cells expressing the E7 
ΔLHCYE mutant (Fig. 5C–D, Table 1). Since the half-life of Chk2 in the E7 ΔLHCYE 
mutant cells extended past our time course, we were unable to determine the full effect of 
loss of the E7 Rb binding domain on Chk2 protein stability. However, the observation that 
the relative levels of Chk2 decrease in the E7 ΔLHCYE mutant at each time point compared 
to HFK-31 cells suggests that the E7 Rb binding domain is important for extending the half-
life of the Chk2 protein. The half-life of Chk1 was also extended in E7-expressing cells, 
increasing to 5.6+/−0.8 h from 3.5+/−0.6 h in control cells. Similar to ATM and Chk2, the 
increase in protein stability was lost in cells expressing the E7 ΔLHYCE mutant (3.9+/−0.3 
h). Taken together, these data indicate that HPV maintains high levels of ATM, as well as 
ATR pathway components by increasing protein stability. Furthermore, these data indicate 
that the increase in half-life observed in HPV31 positive cells occurs in an E7-dependent 
manner through its Rb binding domain.
We next determined if HPV31 also maintains components of the MRN complex by 
increasing protein stability. As shown in Fig. 6A and B and summarized in Table 1, the half-
life of MRE11 was substantially increased from 4.8+/−0.4 h in HFKs to > 12 h in HFK-31 
cells. In contrast, the half-life of MRE11 in HFK-31 ΔLHYCE cells (4.2+/−0.2 h) mirrored 
that found in HFKs. Similarly, the half-life of Rad50 was increased in HFK-31 cells (> 12 h) 
compared to HFKs (8.3+/−0.9 h). We were unable to determine the effect of the ΔLHCYE 
mutation on Rad50 protein stability as the half-life extended beyond our time course (> 12 
h) (Fig. 6B). However, the observation that the relative levels of Rad50 decreased in the E7 
ΔLHCYE mutant at each time point compared to HFK-31 cells suggests that protein stability 
is affected by loss of the Rb binding domain. For NBS1, the half-life increased from 7.1+/
−1.1 h in HFKs to more than 12 h in HFK-31 cells, and was reduced to 9.4+/−1.1 h in 
HFK-31 ΔLHYCE cells. Similar results for the MRN complex components were observed in 
E7-expressing cells (Fig. 6C–D). As shown in Fig. 6C and D and summarized in Table 2, the 
half-lives of MRE11 and NBS1 increased from 3.2+/−0.2 and 5.0+/−0.4 h in HFKs, 
respectively, to > 12 h in cells expressing wild-type E7. In cells expressing the E7 ΔLHYCE 
Johnson et al. Page 10
Virology. Author manuscript; available in PMC 2017 August 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
mutant, the half-lives for MRE11 and NBS1 were reduced to 3.6+/−0.8 and 4.6+/−0.7 h, 
respectively, similar to that found in HFKs (Fig. 6C–D). Similar to the HPV31 genome 
containing lines, the half-life for Rad50 increased to > 12 h in E7-expressing cells compared 
to 8.4+/−0.3 h in HFKs. In cells expressing the E7 ΔLHCYE mutant, we were again unable 
to calculate the half-life of Rad50 based on the 12-h time-course utilized. However, at each 
time point the relative levels of Rad50 were lower in the E7 ΔLHCYE mutant compared to 
wild-type E7-expressing cells, again suggesting that loss of the Rb binding mutant affects 
Rad50 stability. Overall, these data suggest that protein stability is a contributing factor to 
the maintenance of MRN complex members in HPV31 positive cells and this regulation 
occurs through a mechanism requiring Rb binding domain of E7.
As mentioned, we previously reported that BRCA1 and Rad51 exhibit increased protein 
stability in HPV31 positive CIN612 cells (Chappell et al., 2015). We next wanted to 
determine if this phenotype was affected by the E7 ΔLHCYE mutation. As shown in Fig. 7A 
and B and summarized in Table 1, the half-lives of BRCA1 and Rad51 were significantly 
elevated, increasing from 2.9+/−0.3 and 5.4+/−0.2 h in HFKs to 6.0+/−0.5 and 10.2+/−0.3 h 
in HFK-31 cells, respectively. Similar to the other DDR proteins examined, this increased 
stability was lost in HFK-31 ΔLHCYE cells for both BRCA1 (3.0+/−0.3 h) and Rad51 
(4.6+/−0.2 h). Similar results were observed in the E7-expressing cells, as shown in Fig. 7C 
and D and summarized in Table 2. We found the half-lives of BRCA1 and Rad51 increased 
from 3.3+/−0.4 and 5.0+/−1.4 h in HFKs to 6.9+/−0.2 and 12.1+/−1.4 h in E7-expressing 
cells, respectively. In the E7 ΔLHCYE mutant cells, the half-lives decreased to levels similar 
to that found in HFKs for both BRCA1 (2.6+/−0.1 h) and Rad51 (5.0+/−0.9). This data, 
along with our analysis of BRCA1 and Rad51 gene expression (Fig. 4E–F), suggests that 
BRCA1 and Rad51 are regulated by HPV31 both transcriptionally, as well as post-
transcriptionally via protein stability in an E7-dependent manner. Additionally, our data 
indicate that the Rb binding site of E7 contributes to both mechanisms.
4. Discussion
Previous studies demonstrated that activation of both the ATM and ATR DNA damage 
response (DDR) pathways are required for the productive replication of HPV31 (Hong et al., 
2015a; Moody and Laimins, 2009). Expression of E7 alone has been shown to be sufficient 
for activation of both ATM and ATR signaling (Hong et al., 2015a; Rogoff et al., 2004). It is 
well established that E7 plays a central role in facilitating viral replication by binding and 
targeting the degradation of Rb, resulting in S-phase re-entry by a subset of differentiating 
keratinocytes (Banerjee et al., 2006). The introduction of the HPV31 genome, or expression 
of HPV31 E7 alone is sufficient to increase the levels of a broad range of DNA repair factors 
in primary keratinocytes, including ATM, Chk2, Chk1, the MRN complex, BRCA1, and 
Rad51, all of which are required for productive replication (Anacker et al., 2014; Chappell et 
al., 2015; Moody and Laimins, 2009; Rogoff et al., 2004). Interestingly, loss of Rb activity 
has been shown to recapitulate many of these phenotypes (Frame et al., 2006; Pickering and 
Kowalik, 2006), raising the possibility that E7 activates the DDR and provides DNA repair 
factors for productive viral replication through its ability to bind and target Rb for 
degradation. Consistent with this idea, we have found that the E7 Rb binding domain is 
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required for maintenance of ATM and ATR activation, as well as the increased levels of 
DNA repair factors observed in both HPV31 positive and E7-expressing cells.
We have found that deletion of the HPV31 E7 Rb binding domain results in decreased levels 
of both phosphorylated and total levels of ATM, as well as its downstream target Chk2. In 
addition, we have found that this domain is required for maintenance of total and 
phosphorylated levels of Chk1, a target of the ATR DNA damage kinase. The concomitant 
decrease in total levels along with the phosphorylated forms of ATM, Chk2, and Chk1 in E7 
Rb binding deficient cells suggests that in addition to inducing DDR activation, E7 
contributes to maintenance of the DDR through increasing total levels of DNA repair 
factors. Additionally, we show that while total levels of ATM and Chk2 decrease upon 
differentiation in HPV31 positive cells, the phosphorylated forms remain elevated, 
suggesting that the DDR is further activated during the productive phase of the viral life 
cycle. In contrast, loss of the Rb binding domain resulted in a minimal decrease in total 
levels of DDR factors upon differentiation, similar to that observed for uninfected HFKs. In 
cells expressing HPV31 E7 alone, these phenotypes were recapitulated, further highlighting 
the importance of the E7 Rb binding domain in the regulation of these DDR factors in 
HPV31 positive cells.
Our studies demonstrate that loss of the E7 Rb binding site results in reduced levels of all 
three components of the MRN complex (Mre11, Rad50, and Nbs1). The MRN complex is 
required for the activation of ATM in response to DNA damage (Lee and Paull, 2004, 2005; 
Paull and Lee, 2005). However, we previously published that the MRN complex is not 
required for ATM activation in HPV31 positive cells, but is required for productive viral 
replication (Anacker et al., 2014). These results suggest that the decrease observed in ATM 
phosphorylation upon the loss of the Rb binding domain is not due to decreased levels of 
MRN components. In addition, we have found that the levels of the homologous repair 
proteins BRCA1 and Rad51, both of which are also required for productive replication 
(Chappell et al., 2015), are maintained at high levels in HPV31 positive cells and E7-
expressing cells in a manner dependent on the Rb binding domain. Together, these data 
further suggest that the Rb binding domain is required for HPV to maintain adequate levels 
of DNA repair factors required for viral DNA synthesis.
The most well known function of the E7 LXCXE domain is the binding of Rb, resulting in 
its targeted degradation and the constitutive activation of E2F transcription factors. Based on 
this function of E7, the simplest explanation of the reduction in total protein levels observed 
in Rb binding deficient cells is that transcription of DNA repair genes is decreased. In 
support of this, several of these factors are E2F responsive, including ATM, Chk1, BRCA1, 
and Rad51 (Bracken et al., 2004). However, while we found that E2F1 and E2F2 protein 
levels are increased in HPV positive cells in a manner dependent on the Rb binding domain, 
only Chk1, BRCA1, and Rad51 were significantly affected at the transcriptional level by the 
E7 ΔLHCYE mutation, suggesting that the other DNA repair factors examined (ATM, Chk2, 
and MRN) are regulated primarily in a post-transcriptional manner. In support of this, we 
found that all of the DDR proteins examined exhibited some level of regulation at the level 
of protein stability, with five proteins (ATM, Mre11, NBS1, BRCA1, and Rad51) at least 
doubling their half-lives in HPV31 positive and/or E7-expressing cells compared to 
Johnson et al. Page 12
Virology. Author manuscript; available in PMC 2017 August 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
uninfected HFKs. Importantly, this increase in half-life was lost in the ΔLHCYE mutant 
both in the context of the viral genome, as well as in cells expressing E7 alone. Together, 
these observations suggest that E7 uses a two-pronged approach to elevate levels of DNA 
repair factors: increasing the transcription of a subset of DNA repair factors and broadly 
increasing the stability of these proteins. Interestingly, our studies indicate that HPV ensures 
adequate levels of BRCA1 and Rad51 by targeting both the regulation of gene expression 
and protein stability.
The mechanism by which E7 increases the protein stability of DNA repair factors in HPV 
positive cells is currently unclear, although several possibilities exist. E7 has been shown to 
interact with multiple DDR components, including ATM, Rad50, NBS1, and BRCA1 
(Anacker et al., 2014; Moody and Laimins, 2009; Zhang et al., 2005), which may influence 
the stability of these proteins. Importantly, the interaction of E7 with ATM and NBS1 is lost 
upon depletion of the Rb binding domain (Anacker et al., 2014; Moody and Laimins, 2009), 
and whether this affects the stability of these proteins will be the focus of future 
investigations. Another possibility is that E7 influences DDR factor protein stability through 
effects on protein degradation machinery. E7 has been shown to inhibit the anaphase 
promoting complex/cyclosome (APC/C) (Yu and Munger, 2013), a ubiquitin ligase complex 
involved in regulation of mitotic progression, as well as the DDR (de Boer et al., 2016). 
However, whether E7-mediated inhibition of this complex occurs in a manner dependent on 
the Rb binding domain is not known.
We have found that E7 requires the Rb binding domain to maintain ATM, as well as ATR 
activity. ATM has been shown to affect DDR factor stability both directly through 
phosphorylation, as well as indirectly through regulation of proteasomal degradation (Ciccia 
and Elledge, 2010). Therefore, loss of ATM activity in the E7 ΔLHCYE mutant may result 
in decreased stability of downstream targets through either loss of phosphorylation and/or 
increased degradation. The increase in pChk2 observed upon differentiation in HPV31 
positive cells despite decreased total levels supports this possibility. ATM regulates the 
activity of ubiquitin ligases, including MDM2, through phosphorylation, in turn increasing 
the stability of p53, as well as Chk2 (Meek and Anderson, 2009; Kass et al., 2009). ATM 
also regulates the stability of Chk1 through phosphorylation and stabilization of the zinc-
finger like protein ZEB1, which interacts with the deubiquitylase USP7 to prevent 
proteasomal degradation of Chk1 (Zhang et al., 2014). Additionally, p300 is phosphorylated 
and stabilized by ATM in response to DNA damage, and is in turn required for the 
stabilization NBS1 (Jang et al., 2010, 2011). Interestingly, p300 has also been shown to bind 
directly to the LXCXE domain of HPV16 E7 (Bernat et al., 2003), providing a potential 
direct link between the Rb binding site of E7 and the regulation of NBS1 stability. 
Furthermore, previous studies have linked Rb inactivation to ATM activation and DSB 
induction (Pickering and Kowalik, 2006; Shamma et al., 2013, 2009), as well as the control 
of Tip60-dependent acetylation of ATM (Shamma et al., 2013), which is required for ATM 
autophosphorylation and activation. Importantly, recent studies have shown that Tip60 is 
required for productive replication of HPV31 (Hong et al., 2015b), presumably through 
facilitating ATM activation. Determining if the Rb binding domain is required for ATM 
activation through Tip60, as well as whether ATM activity is required for maintenance of 
DDR factor stability in HPV31 positive cells will be important areas of future investigation.
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In addition to increasing protein stability, our studies suggest that E7 elevates transcription 
of a subset of DNA repair genes (Chk1, Rad51, and BRCA1) in a manner dependent on the 
Rb binding domain, though the mechanism by which this occurs is unclear. Previous studies 
demonstrated a requirement for the STAT5 transcription factor in the activation of both the 
ATM and ATR pathways in HPV31 positive cells (Hong et al., 2015a; Hong and Laimins, 
2013). The activation of STAT5 was shown to be E7-dependent and may require the Rb 
binding domain. STAT5 knockdown decreased the total levels of ATM, Chk2, BRCA1, and 
Rad51 in HPV31 positive cells, while only affecting the phosphorylated levels of ATR and 
Chk1 (Hong et al., 2015a; Hong and Laimins, 2013). However, whether the decrease in 
ATM, Chk2, BRCA1, and Rad51 is regulated transcriptionally or post-transcriptionally is 
unclear. Additionally, the expression of both BRCA1 and Rad51 is known to be regulated in 
manner dependent on E2F transcription factors (Bracken et al., 2004), opening the 
possibility that E7 increases their transcription through its ability to inactivate Rb or its 
related pocket proteins p107 and p130. Identifying the mechanism(s) by which E7 regulates 
the transcription of these DNA repair factors will be important to further understand how 
HPV manipulates DNA damage signaling to facilitate viral replication.
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Fig. 1. 
The Rb binding domain of E7 is required for ATM and ATR activation in HPV31 positive 
and E7-expressing keratinocytes. (A) Southern blot analysis performed on DNA harvested at 
the indicated time points from human foreskin keratinocytes maintaining wild-type HPV31 
genomes (HFK-31), as well as HFK-31 cells containing a mutation in the E7 Rb binding site 
(HFK-31 ΔLHCYE). DNA was digested with either BamH1, which does not cut the viral 
genome, or HindIII, which cuts the genome once. The HPV31 genome was used as a probe. 
(B) Western blot analysis was performed on lysates harvested from HFKs, HFK-31 cells, or 
HFK-31 ΔLHCYE cells. Lysates were harvested from undifferentiated cells (T0), as well as 
after 24 and 48hr differentiation in methylcellulose (MC). Primary antibodies used were 
phosphorylated ATM on Ser1981 (pATM), total ATM, phosphorylated Chk2 on Ser68 
(pChk2), total Chk2, phosphorylated Chk1 on Ser345 (pChk1), and total Chk1. GAPDH 
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served as a loading control. Shown are blots representative of five independent experiments 
across four HFK backgrounds. (C) Whole cell lysates were harvested from undifferentiated 
(T0) as well as differentiated (24, 48hr MC) HFKs stably transduced with either a retroviral 
control construct (pLXSN) or retroviral constructs expressing wild-type HPV31 E7 
(pLXSN-31 E7), or HPV31 E7 containing a mutation in the Rb binding domain (pLXSN-31 
E7 ΔLHCYE). Immunoblotting was performed as described in panel B. Western blots shown 
are representative of three independent experiments across two HFK backgrounds.
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Fig. 2. 
Levels of the MRN complex, as well as the homologous recombination proteins BRCA1 and 
Rad51, are maintained in HPV31 positive cells in a manner dependent on the E7 Rb binding 
domain. (A) Whole cell lysates were harvested from HFKs, HFKs stably transfected with 
wild-type HPV31 genomes (HFK-31), or HPV31 genomes with a mutation in the E7 Rb 
binding domain (HFK-31 ΔLHCYE) at T0 (undifferentiated), as well as after 24 and 48hr 
differentiation in methylcellulose (MC). Western blotting was performed using antibodies 
for MRE11, Rad50, and NBS1, with GAPDH serving as a loading control. Western blots 
shown are representative of five independent experiments across four HFK backgrounds. (B) 
Whole cell lysates were harvested from HFKs stably transduced with either the empty 
retroviral vector (pLXSN), wild type HPV31 E7 (pLXSN-31 E7), or an E7 containing a 
mutation in the Rb binding domain (pLXSN-31 E7-ΔLHCYE) at T0 (undifferentiated) as 
well as after 24 and 48hr differentiation in MC. Western blotting was performed with 
antibodies targeting MRE11, Rad50, and NBS1. The blots shown are representative of three 
independent experiments across two HFK backgrounds. (C) Whole cell lysates were 
harvested from HFKs, HFK-31, and HFK-31 ΔLHCYE cells, both at T0 and after 24 and 
48hr differentiation in MC. Western blot analysis was performed for BRCA1 and Rad51, 
with GAPDH serving as a loading control. The data shown is a representative example of 
five independent experiments across four HFK backgrounds. (D) Whole cell lysates were 
harvested from pLXSN, pLXSN-31 E7, and pLXSN-31 E7-ΔLHYCE cells both prior to and 
24 and 48 h post differentiation in MC, and Western blot analysis was performed using 
BRCA1 and Rad51 antibodies, with GAPDH serving as a loading control. Shown is a 
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representative Western blot from three independent experiments across two HFK 
backgrounds.
Johnson et al. Page 20
Virology. Author manuscript; available in PMC 2017 August 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 3. 
The Rb binding domain of E7 is necessary for increased levels of E2F1 and E2F2 in HPV 
positive and E7-expressing keratinocytes. (A) Whole cell lysates were harvested from HFKs, 
HFKs containing wild-type HPV31 genomes (HFK-31), or HPV31 genomes containing an 
E7 Rb deletion mutant (HFK-31 ΔLHCYE) that were undifferentiated (T0) or differentiated 
for 24 or 48 h in methylcellulose (MC). Western blot analysis was performed using 
antibodies to E2F1, E2F2, and E2F3. GAPDH served as a loading control. The Western 
blots shown are representative of five independent experiments across four HFK 
backgrounds. (B) Whole cell lysates were harvested from HFKs stably transduced with a 
retroviral control vector (pLXSN), or vector expressing wild-type HPV31 E7 (pLXSN-31 
E7), or an E7 containing a mutation in the Rb (pLXSN-31 E7-ΔLHCYE) that were 
undifferentiated (T0) or differentiated in methylcellulose for 24 and 48 h. Western blot 
analysis was performed as described in Panel A. Shown are Western blots representative of 
three independent experiments across two HFK backgrounds.
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Fig. 4. 
The E7 Rb binding domain is required for increased transcript levels of Chk1, BRCA1 and 
Rad51. RNA was extracted from undifferentiated (A, C, E) HFKs, HFKs maintaining wild 
type HPV-31 genomes (HFK-31), and HPV-31 genomes containing a deletion in the E7 Rb 
binding site (HFK-31 ΔLHCYE); (B, D, F) or undifferentiated HFKs retrovirally transduced 
with either a control vector (pLXSN), wild type HPV31 E7 (pLXSN-31 E7), or the E7-Rb 
binding mutant (pLXSN-31 E7-ΔLHCYE). Reverse transcription quantitative PCR (RQ-
PCR) was performed using gene-specific primers for ATM, Chk2, and Chk1 (A, B), 
MRE11, Rad50, and NBS1 (C, D), or BRCA1 and Rad51 (E, F). Shown is fold change in 
transcripts calculated using the 2−ΔΔCT method. Values shown are transcript levels relative to 
either HFK (A, C, E) or pLXSN (B, D, F), which are set to 1. Error is indicated as +/− the 
standard error of the mean. Each panel represents the results from four independent 
experiments derived from two different HFK donors. For all panels, the student’s t-test was 
used to test significance. * P≤0.05, and ** P ≤0.01.
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Fig. 5. 
The half-lives of ATM, Chk2 and Chk1 are increased in HPV31 positives cells in an E7-
dependent manner. (A, B) Uninfected HFKs, HFKs maintaining wild type HPV31 genomes 
(HFK-31), HPV31 genomes containing a mutation in the E7 Rb binding site (HFK-31 
ΔLHYCE), as well as (C, D) HFKs stably transduced with a retroviral vector expressing 
wild type E7 (pLXSN-31 E7), or E7 with a mutation in the Rb binding domain (pLXSN-31 
E7 ΔLHCYE) were treated with 50 μg/ml cycloheximide over 12 h time course, with whole 
cell lysates being harvested at the indicated time points. Western blot analysis was 
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performed using antibodies targeting ATM, Chk2, and Chk1, as well as GAPDH, which 
served as a loading control. (A, B) Shown is representative Western blots from three 
independent experiments from two different HFK donors. (C, D) Data shown are 
representative Western blots from three independent experiments from one HFK donor. (B) 
Graphed are the average protein levels of ATM, Chk2, and Chk1 in HFK, HFK-31, and 
HFK-31 ΔLHCYE cells over three independent experiments +/− the standard error of the 
mean. Westerns were digitally imaged using the Bio-Rad Chemidoc MP system, and 
densitometry was performed with the Biorad ImageLab 5.0 software. Values are shown 
relative to each T0, which was set to100. (D) Graphed are the average protein levels of 
ATM, Chk2 and Chk1 in HFKs, pLXSN-E7 and pLXSN E7 ΔLHCYE cells over three 
independent experiments. Densitometry was performed as described above. Error bars 
represent +/− the standard error of the mean.
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Fig. 6. 
The E7 Rb binding domain is necessary for the increased half-lives of MRN complex 
components in HPV31 positive cells. (A, B) Uninfected HFKs, HFKs maintaining wild type 
HPV31 genomes (HFK-31), HPV31 genomes containing a mutation in the E7 Rb binding 
site (HFK-31 ΔLHYCE), as well as (C, D) HFKs stably transduced with a retroviral vector 
expressing wild type E7 (pLXSN-31 E7), or E7 with a mutation in the Rb binding domain 
(pLXSN-31 E7 ΔLHCYE) were treated with 50 μg/ml cycloheximide over 12 h time course, 
and whole cell lysates were harvested at the indicated time points. Western blot analysis was 
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performed using antibodies to MRE11, Rad50, and NBS1, as well as GAPDH, which served 
as a loading control. (A, B) Data shown are representative blots from three independent 
experiments from two different HFK donors, and for (C, D) data shown are representative 
blots from three independent experiments from one HFK donor. (B, D) Graphed are the 
average protein levels of MRE11, Rad50, and NBS1 over three independent experiments. 
Westerns were digitally imaged using the Bio-Rad Chemidoc MP system, and densitometry 
was performed with the Biorad ImageLab 5.0 software. Values are shown relative to each 
T0, which was set to100. Error bars represent +/− the standard error of the mean.
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Fig. 7. 
Increased protein stability in an E7-dependent manner contributes to the increased levels of 
BRCA1 and Rad51 in HPV31 positive cells. (A, B) Primary HFKs, HFKs maintaining wild 
type HPV31 genomes (HFK-31) or mutant HPV31 genomes with a mutation in the Rb 
binding site (HFK-31 ΔLHCYE), as well as (C, D) pLXSN-E7 and pLXSN E7 ΔLHCYE 
cells were treated with 50 μg/ml cycloheximide over a 12 h time course. Whole cell lysates 
were harvest at the indicated times using antibodies to BRCA1 and Rad51, with GAPDH 
serving as a loading control. (A, B) Data shown are representative blots from three 
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independent experiments from two different HFK donors, and for (C, D) data shown are 
representative blots from three independent experiments from one HFK donor. (B, D) 
Graphed are the relative protein levels at each time point, with T0 for each cell line set to 
100. Densitometry was performed across three independent experiments using Biorad 
ImageLab 5.0 software. Error bars represent means +/− standard error.
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Table 1
Protein half-lives for DDR factors in primary HFKs, HFK-31 cells, and HFK-31 ΔLHCYE cells. Half-lives of 
the indicated proteins were determined by performing linear regression on values obtained by densitometry 
from Fig. 5B, Fig. 6B, and Fig. 7B across three independent experiments from two HFK backgrounds. Error 
represents +/− standard error of the mean.
Protein HFK HFK-31 HFK-31 ΔLHCYE
ATM 5.8+/−1.3 > 12 4.5+/−0.8
Chk2 7.0+/−0.02 > 12 9.6+/−2.0
Chk1 4.5+/−0.3 5.8+/−0.5 4.2+/−0.4
MRE11 4.8+/−0.4 > 12 4.2+/−0.2
Rad50 8.3+/−0.9 > 12 > 12
NBS1 7.1+/−1.1 > 12 9.4+/−1.1
BRCA1 2.9+/−0.3 6.0+/−0.5 3.0+/−0.3
Rad51 5.4+/−0.2 10.2+/−0.3 4.6+/−0.2
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Table 2
Protein half-lives for DDR factors in primary HFKs, pLXSN 31-E7 cells, and pLXSN 31-E7 ΔLHCYE cells. 
Linear regression was performed on values obtained by densitometry in Fig. 5D, Fig. 6D, and Fig. 7D to 
determine the half-life of the indicated proteins. Shown are the average half-lives across three independent 
experiments from one HFK background with the error representing +/− standard error of the mean.
Protein HFK 31-E7 31-E7 ΔLHCYE
ATM 4.5+/−0.3 > 12 4.9+/−0.9
Chk2 7.5+/−0.5 > 12 12.3+/−2.7
Chk1 3.5+/−0.6 5.6+/−0.8 3.9+/−0.3
MRE11 3.2+/−0.2 > 12 3.6+/−0.8
Rad50 8.4+/−0.3 > 12 > 12
NBS1 5.0+/−0.3 > 12 4.6+/−0.7
BRCA1 3.3+/−0.4 6.9+/−0.2 2.6+/−0.1
Rad51 5.0+/−1.4 12.1+/−1.4 5.0+/−0.9
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